* Sales grew 26% organically, ahead of expectations * Sweden remains a clear profit driver despite m...
* Q2 sales SEK 10m (vs. ABGSCe SEK 16m, 6.5m Q2'25) * No machine deliveries in Q2, but two machine o...
* Falling CBD and hemp demand plus regulatory uncertainty triggered portfolio-wide liquidations and ...
Redeye updates on Better Collective after Q2-results which were above our forecasts while the compan...
Crunchfish’s Q2 report largely reinforces the investment case outlined in our previous update, with ...
Nabaltec reported H1 figures, which confirm the guided return to growth from Q2.
Angler Gaming levererade ett starkt Q2’26 med en omsättning på 8,45 MEUR (6,64), motsvarande en till...
Redeye raises its forecast again following another impressive quarter.
Vi inleder bevakning på SaveLend, ett svenskt fintechbolag som driver en digital sparplattform där p...
Redeye provides an update following Paxman’s Q2 2026 report.
* Positive organic growth will take time * We slightly lower our sales estimates due to a reduction ...
* Q2 softer than expected, but underlying activity improving * 2026-27 estimates down on softer earn...
* A better mix of growth drivers * Costs reflect investments in the organisation * EV/adj.
Angler Gaming levererar stark tillväxt med omsättningen upp 27 % och bruttomarginalen på 55,1 % i Q2...
* Sales SEK 20m vs. ABGSCe 26m, EBIT roughly in line * Cost control holds EBIT despite soft top line...
Redeye provides a research update following the Q2 report recently published by Initiator Pharma.
* Sales SEK 10m (vs. ABGSCe 16m) driven by Coating Services * No system deliveries in Q2, but two IC...
* Q2 sales 11% higher than ABGSCe SEK 62m * Gross margin down slightly, likely due to unfavourable m...
Sales +21% vs. ABGSCe, EBIT SEK 21m vs. ABGSCe 13m Easy comps, but +91% organic growth still very st...
Redeye provides an initial take following Paxman’s Q2 2026 report.